Farid M, Ngeow J. Sarcomas associated with genetic cancer predisposition syndromes: a review. Oncologist. 2016;21(8):1002–13.

Article  PubMed  PubMed Central  Google Scholar 

Bridge JA. The role of cytogenetics and molecular diagnostics in the diagnosis of soft-tissue tumors. Mod Pathol. 2014;27(Suppl 1):S80-97.

Article  PubMed  Google Scholar 

Szurian K, Kashofer K, Liegl-Atzwanger B. Role of next-generation sequencing as a diagnostic tool for the evaluation of bone and soft-tissue tumors. Pathobiology. 2017;84(6):323–38.

Article  CAS  PubMed  Google Scholar 

Henderson-Jackson EB, Bui MM. Molecular pathology of soft-tissue neoplasms and its role in clinical practice. Cancer Control. 2015;22(2):186–92.

Article  PubMed  Google Scholar 

WHO. Classification of tumours editorial board. Soft tissue and bone tumours. 5th ed. Lyon: WHO Classification of Tumours Series, International Agency for Research on Cancer; 2020;3. https://publications.iarc.fr/588

Bridge JA, Sandberg AA. Cytogenetic and molecular genetic techniques as adjunctive approaches in the diagnosis of bone and soft tissue tumors. Skeletal Radiol. 2000;29(5):249–58.

Article  CAS  PubMed  Google Scholar 

Netto GJ, Saad RD, Dysert PA 2nd. Diagnostic molecular pathology: current techniques and clinical applications, part I. Proc (Bayl Univ Med Cent). 2003;16(4):379–83.

PubMed  Google Scholar 

Bishop R. Applications of fluorescence in situ hybridization (FISH) in detecting genetic aberrations of medical significance. Biosci Horiz Int J Stud Res. 2010;3(1):85–95.

Article  CAS  Google Scholar 

Murphey MD, Arcara LK, Fanburg-Smith J. From the archives of the AFIP: imaging of musculoskeletal liposarcoma with radiologic-pathologic correlation. Radiographics. 2005;25(5):1371–95.

Article  PubMed  Google Scholar 

Kransdorf M, Murphey MD. Imaging of soft tissue tumors, 2nd ed. Lippincott Williams & Wilkins; 2006.

Gaskin CM, Helms CA. Lipomas, lipoma variants, and well-differentiated liposarcomas (atypical lipomas): results of MRI evaluations of 126 consecutive fatty masses. AJR Am J Roentgenol. 2004;182(3):733–9.

Article  PubMed  Google Scholar 

Gupta P, Potti TA, Wuertzer SD, Lenchik L, Pacholke DA. Spectrum of fat-containing soft-tissue masses at MR imaging: the common, the uncommon, the characteristic, and the sometimes confusing. Radiographics. 2016;36(3):753–66.

Article  PubMed  Google Scholar 

Shannon BA, Ahlawat S, Morris CD, Levin AS, Fayad LM. Do contrast-enhanced and advanced MRI sequences improve diagnostic accuracy for indeterminate lipomatous tumors? Radiol Med. 2022;127(1):90–9.

Article  PubMed  Google Scholar 

Yao X, Ghert M, Dickson BC, et al. An evidence-based guideline on the application of molecular testing in the diagnosis, prediction of prognosis, and selection of therapy in non-GIST soft tissue sarcomas. Cancer Treat Rev. 2020;85:101987.

Article  CAS  PubMed  Google Scholar 

Choi JH, Ro JY. The 2020 WHO classification of tumors of soft tissue: selected changes and new entities. Adv Anat Pathol. 2021;28(1):44–58.

Article  PubMed  Google Scholar 

Chen BJ, Mariño-Enríquez A, Fletcher CD, Hornick JL. Loss of retinoblastoma protein expression in spindle cell/pleomorphic lipomas and cytogenetically related tumors: an immunohistochemical study with diagnostic implications. Am J Surg Pathol. 2012;36(8):1119–28.

Article  PubMed  Google Scholar 

Bartuma H, Hallor KH, Panagopoulos I, et al. Assessment of the clinical and molecular impact of different cytogenetic subgroups in a series of 272 lipomas with abnormal karyotype. Genes Chromosomes Cancer. 2007;46(6):594–606.

Article  CAS  PubMed  Google Scholar 

Sciot R, Akerman M, Dal Cin P, et al. Cytogenetic analysis of subcutaneous angiolipoma: further evidence supporting its difference from ordinary pure lipomas: a report of the CHAMP Study Group. Am J Surg Pathol. 1997;21(4):441–4.

Article  CAS  PubMed  Google Scholar 

Nord KH, Magnusson L, Isaksson M, et al. Concomitant deletions of tumor suppressor genes MEN1 and AIP are essential for the pathogenesis of the brown fat tumor hibernoma. Proc Natl Acad Sci U S A. 2010;107(49):21122–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gisselsson D, Hibbard MK, Dal Cin P, et al. PLAG1 alterations in lipoblastoma: involvement in varied mesenchymal cell types and evidence for alternative oncogenic mechanisms. Am J Pathol. 2001;159(3):955–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bui NQ, Przybyl J, Trabucco SE, et al. A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis. Clin Sarcoma Res. 2019;11(9):12.

Article  Google Scholar 

Creytens D, Folpe AL, Koelsche C, et al. Myxoid pleomorphic liposarcoma-a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcoma. Mod Pathol. 2021;34(11):2043–9.

Article  CAS  PubMed  Google Scholar 

Dermawan JK, Hwang S, Wexler L, et al. Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic study. Mod Pathol. 2022;35(11):1644–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghadimi MP, Liu P, Peng T, et al. Pleomorphic liposarcoma: clinical observations and molecular variables. Cancer. 2011;117(23):5359–69.

Article  CAS  PubMed  Google Scholar 

Ryan S, Visgauss J, Kerr D, et al. The value of MRI in distinguishing subtypes of lipomatous extremity tumors needs reassessment in the era of mdm2 and cdk4 testing. Sarcoma. 2018;2018:1901896.

Article  PubMed  PubMed Central  Google Scholar 

Reimann JDR, Fletcher CDM. Soft tissue sarcomas. In: Mendelsohn J, Gray JW, Howley PM, Israel MA, Thompson CB, editors. The molecular basis of cancer. 4th ed. W.B. Saunders; 2015. pp. 609–618.

Gambella A, Bertero L, Rondón-Lagos M, et al. FISH diagnostic assessment of MDM2 amplification in liposarcoma: potential pitfalls and troubleshooting recommendations. Int J Mol Sci. 2023;24(2):1342.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kandel RA, Yao X, Dickson BC, et al. Molecular analyses in the diagnosis and prediction of prognosis in non-GIST soft tissue sarcomas: a systematic review and meta-analysis. Cancer Treat Rev. 2018;66:74–8.

Article  CAS  PubMed  Google Scholar 

Vogenberg FR, Barash C, Pursel M. Personalized medicine: part 1: evolution and development into theranostics. P T. 2010;35(10):560–76.

PubMed  PubMed Central  Google Scholar 

O’Regan KN, Jagannathan J, Krajewski K, et al. Imaging of liposarcoma: classification, patterns of tumor recurrence, and response to treatment. AJR Am J Roentgenol. 2011;197(1):W37-43.

Article  PubMed  Google Scholar 

Powers MP, Wang WL, Hernandez VS, et al. Detection of myxoid liposarcoma-associated FUS-DDIT3 rearrangement variants including a newly identified breakpoint using an optimized RT-PCR assay. Mod Pathol. 2010;23(10):1307–15.

Article  CAS  PubMed  Google Scholar 

Sung MS, Kang HS, Suh JS, et al. Myxoid liposarcoma: appearance at MR imaging with histologic correlation. Radiographics. 2000;20(4):1007–19.

Article  CAS  PubMed  Google Scholar 

Benhabib H, Brandenberger D, Lajkosz K, et al. MRI radiomics analysis in the diagnostic differentiation of malignant soft tissue myxoid sarcomas from benign soft tissue musculoskeletal myxomas. J Magn Reson Imaging. 2025. https://doi.org/10.1002/jmri.29691.Advanceonlinepublication.

Article  PubMed  Google Scholar 

Sunitsch S, Gilg MM, Kashofer K, Gollowitsch F, Leithner A, Liegl-Atzwanger B. Detection of GNAS mutations in intramuscular / cellular myxomas as diagnostic tool in the classification of myxoid soft tissue tumors. Diagn Pathol. 2018;13(1):52.

Article  PubMed  PubMed Central  Google Scholar 

Bekers EM, Eijkelenboom A, Rombout P, et al. Identification of novel GNAS mutations in intramuscular myxoma using next-generation sequencing with single-molecule tagged molecular inversion probes. Diagn Pathol. 2019;14(1):15.